Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Novo Nordisk A/S
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Informed consent obtained before any study-related activities (Study-related activities are any procedure related to recording of data according to the protocol)
Male or female patients at least 18 years of age at time of informed consent
T1DM (diagnosed clinically) prior to inclusion in the study, and/or T2DM, insulin using patients (diagnosed clinically) prior to inclusion in the study
Planned initiation with Tresiba®
You may not be if
Known or suspected hypersensitivity to Tresiba® or any of the excipients listed in Section 6.1 of the SmPC (Summary of Product Characteristics) or related products
Previous participation in this study (i.e. provision of informed consent)
Patients who have previously been treated with Tresiba®
Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
